X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
clinical research/practice (11) 11
surgery (10) 10
transplantation (10) 10
kidney transplantation (9) 9
immunosuppression (8) 8
kidney transplantation/nephrology (8) 8
analysis (7) 7
immunosuppression/immune modulation (7) 7
kidneys (7) 7
clinical trials (6) 6
cyclosporine (6) 6
cyclosporins (6) 6
immunotherapy (6) 6
calcineurin (5) 5
clinical research (5) 5
graft rejection (5) 5
immunosuppressive agents (5) 5
practice (5) 5
tacrolimus (5) 5
transplants & implants (5) 5
calcineurin inhibitors (4) 4
immune modulation (4) 4
immunosuppressant - calcineurin inhibitor (4) 4
immunosuppressant ‐ calcineurin inhibitor (4) 4
index medicus (4) 4
nephrology (4) 4
organ transplant recipients (4) 4
recipients (4) 4
antibodies (3) 3
biopsy (3) 3
histocompatibility antigen hla (3) 3
immunosuppressant - calcineurin inhibitor: cyclosporine a (3) 3
immunosuppressant ‐ calcineurin inhibitor: cyclosporine a (3) 3
kidney-transplantation (3) 3
medical research (3) 3
medicine, experimental (3) 3
monoclonal antibodies (3) 3
outcomes (3) 3
rejection (3) 3
renal function (3) 3
risk (3) 3
transplantation of organs, tissues, etc (3) 3
antibody biology (2) 2
basic research (2) 2
basic research/science (2) 2
brief communication (2) 2
brief communications (2) 2
calcineurin inhibitor (2) 2
calcineurin inhibitor therapy (2) 2
cancer (2) 2
clinical outcomes (2) 2
clinical trial (2) 2
cyclosporin a (2) 2
cyclosporine a (2) 2
efficacy (2) 2
exposure (2) 2
follow-up (2) 2
glomerular filtration rate (2) 2
immunoglobulins (2) 2
immunosuppressant - calcineurin inhibitor: tacrolimus (2) 2
immunosuppressant - mechanistic target of rapamycin (2) 2
immunosuppressant - mechanistic target of rapamycin: everolimus (2) 2
immunosuppressant ‐ calcineurin inhibitor: tacrolimus (2) 2
immunosuppressant ‐ mechanistic target of rapamycin (2) 2
immunosuppressant ‐ mechanistic target of rapamycin: everolimus (2) 2
immunosuppressant: antiproliferative agent (2) 2
immunosuppressant: calcineurin inhibitor (2) 2
immunosuppressant: steroid (2) 2
kidney diseases (2) 2
lymphocytes (2) 2
mammalian target (2) 2
melanoma (2) 2
metaanalysis (2) 2
multicenter (2) 2
mycophenolate-mofetil (2) 2
oncology, experimental (2) 2
patients (2) 2
pharmacology (2) 2
phase-iii (2) 2
proteins (2) 2
rapamycin inhibitors (2) 2
research (2) 2
science (2) 2
sirolimus (2) 2
standards (2) 2
t cells (2) 2
translational research/science (2) 2
abcb1 genotype (1) 1
adoptive transfer (1) 1
alloantibody (1) 1
allograft-rejection (1) 1
animal models (1) 1
animal models: murine (1) 1
animals (1) 1
antigens (1) 1
apoptosis (1) 1
basicresearch/science (1) 1
belatacept (1) 1
cancer incidence (1) 1
cancer/malignancy/neoplasia (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Transplantation, ISSN 1600-6135, 12/2018, Volume 18, Issue 12, pp. 2965 - 2976
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 07/2018, Volume 18, Issue 7, pp. 1726 - 1734
Journal Article
Journal Article
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 04/2016, Volume 16, Issue 4, pp. 1139 - 1147
Transplant recipients face an increased risk of cancer compared with the healthy population. Although several studies have examined the direct effects of... 
animal models: murine | mechanistic target of rapamycin (mTOR) | immunosuppressant; calcineurin inhibitor | immunosuppression/immune modulation | organ transplantation in general | cyclosporine A (CsA) | immunosuppressant | cancer/malignancy/neoplasia | rejection | basic (laboratory) research/science | RAPAMYCIN | SURGERY | basic (laboratory) research | ALLOGRAFT-REJECTION | malignancy | calcineurin inhibitor | immunosuppression | neoplasia | TRANSPLANTATION | KIDNEY-TRANSPLANT RECIPIENTS | MELANOMA | ADOPTIVE TRANSFER | MEMORY | SIROLIMUS | CANCER INCIDENCE | RENAL-TRANSPLANTATION | science | cancer | immune modulation | DIFFERENTIATION | T-Box Domain Proteins - physiology | Graft Rejection - drug therapy | Graft Survival - immunology | Cyclosporine - pharmacology | Melanoma, Experimental - drug therapy | Mice, Inbred C57BL | Melanoma, Experimental - pathology | Male | Sirolimus - pharmacology | Mice, Knockout | Animals | Melanoma, Experimental - immunology | Immune Tolerance - immunology | Female | Skin Transplantation | Mice | Graft Rejection - immunology | CD8-Positive T-Lymphocytes - immunology | Graft Survival - drug effects | Immunosuppressive Agents - pharmacology | Immune Tolerance - drug effects | Antigens | Analysis | Oncology, Experimental | Immunotherapy | Melanoma | Transplantation of organs, tissues, etc | Genetic engineering | Skin | Research | T cells | Immunosuppressive agents | Cancer | Plastic surgery | T cell receptors | Lymphocytes | Skin & tissue grafts
Journal Article
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 06/2019, Volume 19, Issue 6, pp. 1759 - 1769
Journal Article
Journal Article
Journal Article
Journal Article
Book Chapter